1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Drug Makers Agree to $421 Million Settlement

  1. Guttz
    WASHINGTON—Three U.S. drug makers and their affiliates have agreed to settle federal charges that they engaged in a scheme to report inflated drug prices to get higher reimbursements from government medical-care programs.

    Abbott Laboratories Inc., B. Braun Medical Inc., Roxane Laboratories Inc. and affiliated entities have agreed to pay $421 million to settle the charges, the Justice Department said.

    The drug makers are accused of reporting to national pricing lists inflated costs for certain drugs. The government used those lists to reimburse physicians and pharmacies under Medicare and Medicaid. In essence, doctors and physicians bought drugs from the manufacturers at a lower price, were reimbursed by the government at a higher price and pocketed the difference, the Justice Department said.

    The scheme cost taxpayers "many millions" of dollars in false payments, Justice officials said.

    The arrangement gave doctors and pharmacies a big incentive to prescribe the three drug makers' products, Justice officials said.

    "Medicare and Medicaid in essence footed the bill for Abbott's marketing budget," said Wilfredo Ferrer, U.S. attorney for the Southern District of Florida.

    Abbott spokesman Scott Stoffel said the company believes it has "complied with all laws and regulations" and it agreed to the settlement "to eliminate the uncertainty associated with continued litigation."

    The Abbott Park, Ill., maker of the anti-inflammatory drug Humira previously booked a reserve for the settlement and it won't affect fourth-quarter earnings, Mr. Stoffel said.

    By Josh Mitchell


  1. Killa Weigha
    Yeah, I believe "fraud" is the term they were looking for.
    This is called "bribery"
    This is "spin" and translates to, "we can't figure out how to get out of this crime".
    Say it with me, "da-mage con-trol".
    Finally, this is what corporations do when there is no way to slither out of a crime commited against the American public.

    In the end just another cost of doing business in America. What a country!
To make a comment simply sign up and become a member!